Linde India Ltd

Linde India Ltd

₹ 6,208 -0.68%
01 Apr 12:58 p.m.
About

Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]

Key Points

Business Segment
Gas and Related Products: It comprises of pipeline gas supplies to large industrial customers like primary steel, glass and chemical industries, supply of liquefied gases through Cryogenic tankers (Bulk) to cater to demand across a wide range of industrial sectors and compressed gas supply in cylinders (Packaged Gas) for meeting smaller demand for gases mainly across fabrication, manufacturing and construction industry.
Healthcare business: It provides high quality gases for pharmaceutical use such as medical oxygen, synthetic air and nitrous oxide in addition to providing state of the art medical gas distribution systems to major hospitals.
Project Engineering division (PED): It comprises the business of design, engineering, supply, installation, testing and commissioning of Air Separation plants and related projects on turnkey basis. [1][2]

  • Market Cap 52,942 Cr.
  • Current Price 6,208
  • High / Low 9,935 / 5,380
  • Stock P/E 120
  • Book Value 421
  • Dividend Yield 0.06 %
  • ROCE 17.4 %
  • ROE 13.0 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 75.9% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 21.8%

Cons

  • Stock is trading at 14.6 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
644 534 588 686 697 630 721 711 706 630 653 634 606
496 403 453 542 529 444 557 538 520 452 469 456 414
Operating Profit 148 132 135 144 168 186 164 174 186 179 184 179 192
OPM % 23% 25% 23% 21% 24% 30% 23% 24% 26% 28% 28% 28% 32%
4 16 11 38 22 22 20 21 25 19 21 18 22
Interest 1 1 1 1 1 2 1 1 1 4 2 2 2
Depreciation 46 46 46 44 48 66 49 50 51 52 51 52 55
Profit before tax 105 101 98 137 141 141 134 143 159 142 152 143 157
Tax % 35% 35% -75% 34% 22% 30% 25% 24% 25% 26% 25% 26% 26%
68 66 172 91 110 99 100 109 120 105 114 106 116
EPS in Rs 7.95 7.74 20.15 10.66 12.90 11.64 11.71 12.75 14.08 12.36 13.33 12.48 13.64
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Mar 2023 15m Mar 2024 TTM
1,825 2,033 2,192 1,762 1,471 2,112 3,136 2,769 2,524
1,539 1,705 1,866 1,347 1,096 1,564 2,371 2,066 1,790
Operating Profit 287 328 326 415 375 548 765 702 734
OPM % 16% 16% 15% 24% 25% 26% 24% 25% 29%
40 8 15 862 36 335 113 85 81
Interest 116 116 103 86 6 3 6 7 10
Depreciation 195 206 199 177 176 181 253 201 210
Profit before tax 16 13 39 1,013 229 698 618 579 595
Tax % -20% -21% 35% 28% 34% 27% 13% 25%
19 16 26 727 151 507 538 434 442
EPS in Rs 2.23 1.90 3.01 85.27 17.72 59.47 63.09 50.90 51.81
Dividend Payout % 34% 53% 50% 12% 17% 23% 19% 24%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: 23%
TTM: -9%
Compounded Profit Growth
10 Years: %
5 Years: 76%
3 Years: 42%
TTM: 3%
Stock Price CAGR
10 Years: 31%
5 Years: 68%
3 Years: 18%
1 Year: -3%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 15%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Mar 2023 Mar 2024 Sep 2024
Equity Capital 85 85 85 85 85 85 85 85 85
Reserves 1,356 1,365 1,377 2,087 2,149 2,630 3,055 3,383 3,501
1,445 1,282 1,199 108 7 24 22 21 42
722 680 759 970 1,045 1,277 1,238 1,316 1,307
Total Liabilities 3,608 3,412 3,420 3,250 3,286 4,017 4,400 4,805 4,936
2,573 2,498 2,162 2,035 1,989 1,869 1,762 1,822 1,817
CWIP 80 36 44 53 17 68 225 483 791
Investments 61 58 0 0 4 9 32 50 32
895 821 1,214 1,162 1,276 2,071 2,380 2,450 2,297
Total Assets 3,608 3,412 3,420 3,250 3,286 4,017 4,400 4,805 4,936

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Mar 2023 Mar 2024
293 252 376 327 339 589 629 437
-128 -59 -73 981 -54 98 -306 -539
-80 -261 -216 -1,193 -201 -28 -119 -105
Net Cash Flow 85 -68 87 115 84 659 203 -208

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Mar 2023 Mar 2024
Debtor Days 71 63 61 79 101 73 47 63
Inventory Days 102 91 66 57 72 37 22 32
Days Payable 447 348 293 327 477 312 156 235
Cash Conversion Cycle -274 -194 -166 -190 -303 -202 -87 -139
Working Capital Days -50 -42 -33 -24 13 -3 -9 -11
ROCE % 5% 5% 10% 10% 17% 21% 17%

Shareholding Pattern

Numbers in percentages

Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
2.59% 2.65% 2.77% 2.80% 2.77% 2.85% 2.89% 2.25% 2.31% 3.03% 2.42% 2.27%
8.31% 7.97% 7.77% 7.80% 8.01% 7.76% 7.44% 7.22% 7.45% 6.84% 6.88% 6.81%
14.10% 14.38% 14.45% 14.39% 14.23% 14.38% 14.67% 15.52% 15.23% 15.13% 15.70% 15.92%
No. of Shareholders 48,53751,97450,99550,48144,45744,13749,72454,66152,22160,13863,32466,819

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls